Deals

More deals, page 179766

Every deal below is 13–97% off the listed price. Prices sync in real time from verified stores.

Nihon Kohden Corporation (6849.T) DCF Valuation
-40%

Nihon Kohden Corporation (6849.T) DCF Valuation

dcfmodeling.comPLPL
PLN 15.00PLN 25.00
Nihon Kohden Corporation (6849.T): PESTLE Analysis [Dec-2025 Updated]
-22%

Nihon Kohden Corporation (6849.T): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Nihon Kohden Corporation (6849.T): VRIO Analysis
-22%

Nihon Kohden Corporation (6849.T): VRIO Analysis

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Nihon Kohden Corporation (6849.T): SWOT Analysis [Dec-2025 Updated]
-22%

Nihon Kohden Corporation (6849.T): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Nihon Kohden Corporation (6849.T): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Nihon Kohden Corporation (6849.T): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK): Ansoff Matrix
-22%

Ascentage Pharma Group International (6855.HK): Ansoff Matrix

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK): BCG Matrix [Dec-2025 Updated]
-22%

Ascentage Pharma Group International (6855.HK): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK): Marketing Mix Analysis
-22%

Ascentage Pharma Group International (6855.HK): Marketing Mix Analysis

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK): Canvas Business Model
-22%

Ascentage Pharma Group International (6855.HK): Canvas Business Model

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK) DCF Valuation
-40%

Ascentage Pharma Group International (6855.HK) DCF Valuation

dcfmodeling.comPLPL
PLN 15.00PLN 25.00
Ascentage Pharma Group International (6855.HK): PESTLE Analysis [Dec-2025 Updated]
-22%

Ascentage Pharma Group International (6855.HK): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK): VRIO Analysis
-22%

Ascentage Pharma Group International (6855.HK): VRIO Analysis

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK): SWOT Analysis [Dec-2025 Updated]
-22%

Ascentage Pharma Group International (6855.HK): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Ascentage Pharma Group International (6855.HK): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Ascentage Pharma Group International (6855.HK): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T): Ansoff Matrix
-22%

HORIBA, Ltd. (6856.T): Ansoff Matrix

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T): Canvas Business Model
-22%

HORIBA, Ltd. (6856.T): Canvas Business Model

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T): BCG Matrix [Dec-2025 Updated]
-22%

HORIBA, Ltd. (6856.T): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T) DCF Valuation
-40%

HORIBA, Ltd. (6856.T) DCF Valuation

dcfmodeling.comPLPL
PLN 15.00PLN 25.00
HORIBA, Ltd. (6856.T): PESTLE Analysis [Dec-2025 Updated]
-22%

HORIBA, Ltd. (6856.T): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T): Marketing Mix Analysis
-22%

HORIBA, Ltd. (6856.T): Marketing Mix Analysis

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T): 5 FORCES Analysis [Dec-2025 Updated]
-22%

HORIBA, Ltd. (6856.T): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T): SWOT Analysis [Dec-2025 Updated]
-22%

HORIBA, Ltd. (6856.T): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
Advantest Corporation (6857.T): Ansoff Matrix
-22%

Advantest Corporation (6857.T): Ansoff Matrix

dcfmodeling.comPLPL
PLN 7.00PLN 9.00
HORIBA, Ltd. (6856.T): VRIO Analysis
-22%

HORIBA, Ltd. (6856.T): VRIO Analysis

dcfmodeling.comPLPL
PLN 7.00PLN 9.00